Your browser doesn't support javascript.
loading
Neoadjuvant Sequential Docetaxel Followed by High-Dose Epirubicin in Combination With Cyclophosphamide Administered Concurrently With Trastuzumab. The DECT Trial.
Pizzuti, Laura; Barba, Maddalena; Giannarelli, Diana; Sergi, Domenico; Botti, Claudio; Marchetti, Paolo; Anzà, Michele; Maugeri-Saccà, Marcello; Natoli, Clara; Di Filippo, Simona; Catenaro, Teresa; Tomao, Federica; Amodio, Antonella; Carpano, Silvia; Perracchio, Letizia; Mottolese, Marcella; Di Lauro, Luigi; Sanguineti, Giuseppe; Di Benedetto, Anna; Giordano, Antonio; Vici, Patrizia.
Afiliación
  • Pizzuti L; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Barba M; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Giannarelli D; Scientific Direction, Regina Elena National Cancer Institute, Rome, Italy.
  • Sergi D; Biostatistics Unit, Regina Elena National Cancer Institute, Rome, Italy.
  • Botti C; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Marchetti P; Department of Surgery, Regina Elena National Cancer Institute, Rome, Italy.
  • Anzà M; Oncology Unit, Sant'Andrea Hospital, La Sapienza University of Rome, Rome, Italy.
  • Maugeri-Saccà M; Department of Surgery, Regina Elena National Cancer Institute, Rome, Italy.
  • Natoli C; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Di Filippo S; Scientific Direction, Regina Elena National Cancer Institute, Rome, Italy.
  • Catenaro T; Department of Medical, Oral and Biotechnological Sciences and CeSI-MeT, G. d'Annunzio University, Chieti, Italy.
  • Tomao F; Santa Maria Goretti, Hospital of Latina, Latina, Italy.
  • Amodio A; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Carpano S; Department of Gynecologic Oncology, University "Sapienza", Rome, Italy.
  • Perracchio L; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Mottolese M; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Di Lauro L; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy.
  • Sanguineti G; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy.
  • Di Benedetto A; Division of Medical Oncology 2, Regina Elena National Cancer Institute, Rome, Italy.
  • Giordano A; Department of Radiation Oncology, Regina Elena National Cancer Institute, Rome, Italy.
  • Vici P; Department of Pathology, Regina Elena National Cancer Institute, Rome, Italy.
J Cell Physiol ; 231(11): 2541-7, 2016 Nov.
Article en En | MEDLINE | ID: mdl-27187274
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Epirrubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Ciclofosfamida / Taxoides / Trastuzumab Tipo de estudio: Guideline Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Cell Physiol Año: 2016 Tipo del documento: Article País de afiliación: Italia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Epirrubicina / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Neoadyuvante / Ciclofosfamida / Taxoides / Trastuzumab Tipo de estudio: Guideline Límite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: J Cell Physiol Año: 2016 Tipo del documento: Article País de afiliación: Italia